a significant trendP = .012
The ITS analyses confirmed a significant trend in the decrease of intravenous (IV) vancomycin utilization ( P = .012) ( Appendix Figure 3 ); however, despite overall reductions, there were no significant decreases in slopes of any additional antimicrobial category, including total antimicrobial ( Figure 2 ) and fluoroquinolone utilization ( P = .709) ( Appendix Figure 4 ).